Literature DB >> 16585467

Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.

Lee S Cohen1, Claudio N Soares, Allison F Vitonis, Michael W Otto, Bernard L Harlow.   

Abstract

CONTEXT: Transition to menopause has long been considered a period of increased risk for depressive symptoms. However, it is unclear whether this period is one of increased risk for major depressive disorder, particularly for women who have not had a previous episode of depression.
OBJECTIVE: To examine the association between the menopausal transition and onset of first lifetime episode of depression among women with no history of mood disturbance.
DESIGN: Longitudinal, prospective cohort study.
SETTING: A population-based cross-sectional sample. PARTICIPANTS: Premenopausal women, 36 to 45 years of age, with no lifetime diagnosis of major depression (N = 460), residing in 7 Boston, Mass, metropolitan area communities. Main Outcome Measure Incidence of new onset of depression based on structured clinical interviews, Center for Epidemiologic Studies Depression Scale scores, and an operational construct for depression.
RESULTS: Premenopausal women with no lifetime history of major depression who entered the perimenopause were twice as likely to develop significant depressive symptoms as women who remained premenopausal, after adjustment for age at study enrollment and history of negative life events. The increased risk for depression was somewhat greater in women with self-reported vasomotor symptoms.
CONCLUSIONS: The current study suggests that within a similarly aged population of women with no lifetime history of depression, those who enter the menopausal transition earlier have a significant risk for first onset of depression. Further studies are needed to determine more definitively whether other factors, such as the presence of vasomotor symptoms, use of hormone therapy, and the occurrence of adverse life events, independently modify this risk. Physical symptoms associated with the menopausal transition and mood changes seen during this period may affect many women as they age and may lead to a significant burden of illness.

Entities:  

Mesh:

Year:  2006        PMID: 16585467     DOI: 10.1001/archpsyc.63.4.385

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  209 in total

Review 1.  Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Authors:  Christopher Harshaw
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).

Authors:  Joyce T Bromberger; Laura L Schott; Howard M Kravitz; Maryfran Sowers; Nancy E Avis; Ellen B Gold; John F Randolph; Karen A Matthews
Journal:  Arch Gen Psychiatry       Date:  2010-06

3.  Validation of POMS questionnaire in postmenopausal women.

Authors:  Kathleen W Wyrwich; Holly Yu
Journal:  Qual Life Res       Date:  2011-01-29       Impact factor: 4.147

4.  Depressive symptoms and self-reported fast-food intake in midlife women.

Authors:  Geoffrey B Crawford; Anuprita Khedkar; Jodi A Flaws; John D Sorkin; Lisa Gallicchio
Journal:  Prev Med       Date:  2011-01-27       Impact factor: 4.018

Review 5.  Perimenopause and cognition.

Authors:  Gail A Greendale; Carol A Derby; Pauline M Maki
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

Review 6.  Factors that may influence the experience of hot flushes by healthy middle-aged women.

Authors:  Ayelet Ziv-Gal; Jodi A Flaws
Journal:  J Womens Health (Larchmt)       Date:  2010-10       Impact factor: 2.681

7.  Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition.

Authors:  Pauline M Maki; Ellen W Freeman; Gail A Greendale; Victor W Henderson; Paul A Newhouse; Peter J Schmidt; Nelda F Scott; Carol A Shively; Claudio N Soares
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

8.  Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.

Authors:  Paul A Newhouse; Julie Dumas; Heather Wilkins; Emily Coderre; Cynthia K Sites; Magdalena Naylor; Chawki Benkelfat; Simon N Young
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

9.  Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States.

Authors:  Katherine M Keyes; Keely Cheslack-Postava; Carolyn Westhoff; Christine M Heim; Michelle Haloossim; Kate Walsh; Karestan Koenen
Journal:  Am J Epidemiol       Date:  2013-09-15       Impact factor: 4.897

10.  Economic pressure and depressive symptoms: Testing the family stress model from adolescence to adulthood.

Authors:  Shane A Kavanaugh; Tricia K Neppl; Janet N Melby
Journal:  J Fam Psychol       Date:  2018-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.